Gold Bond Asbestos Cement Board

Product Description

Gold Bond Asbestos Cement Board was a construction and industrial building material manufactured by National Gypsum Company under its well-known Gold Bond product line. Produced during the decade spanning 1943 through 1953, this rigid board product was marketed for use in applications requiring durability, fire resistance, and dimensional stability under demanding industrial conditions.

National Gypsum Company was one of the largest gypsum and building materials manufacturers in the United States throughout much of the twentieth century, and the Gold Bond brand became widely associated with wallboard, ceiling tile, and specialty construction products. The Asbestos Cement Board was among the specialty offerings produced during a period when asbestos-containing materials were in widespread industrial and commercial use across American worksites.

Although categorized in part within the pipe insulation sector, asbestos cement board products of this type served a range of industrial functions. They were used as protective panels, thermal barriers, and structural backing in settings where heat, moisture, or mechanical stress made conventional materials impractical. The product’s relatively rigid composition distinguished it from softer asbestos insulating materials, though its fiber content presented comparable exposure hazards during handling, cutting, and installation.

Production of this product ceased in 1953, placing it within the historical window during which awareness of asbestos health hazards within the general workforce was limited and regulatory controls on fiber exposure were absent or unenforced.

Asbestos Content

Gold Bond Asbestos Cement Board contained chrysotile asbestos, the most commonly used asbestos fiber type in American commercial and industrial products throughout the mid-twentieth century. Chrysotile, sometimes called “white asbestos,” belongs to the serpentine mineral group and was incorporated into cement board products for several practical reasons.

In cement board applications, chrysotile fibers were mixed with Portland cement and other binding agents to create a composite material with reinforced tensile strength. The asbestos fibers distributed throughout the matrix gave the finished board resistance to cracking and fracture while contributing to its fire-resistant and thermally insulating properties. These characteristics made asbestos cement board products commercially attractive for industrial environments where building panels and thermal barriers were regularly subjected to heat and physical stress.

Although chrysotile has sometimes been distinguished from amphibole asbestos varieties in discussions of relative toxicity, regulatory and public health authorities including the Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA), and the World Health Organization (WHO) have consistently identified chrysotile as a human carcinogen capable of causing mesothelioma, asbestosis, and lung cancer when inhaled. No safe level of occupational exposure to chrysotile asbestos has been established under current scientific consensus.

The Asbestos Hazard Emergency Response Act (AHERA), enacted in 1986, established federal standards for identifying and managing asbestos-containing materials, including cement board products, recognizing the ongoing hazard posed by legacy materials installed in prior decades.

How Workers Were Exposed

Workers exposed to Gold Bond Asbestos Cement Board were primarily industrial workers employed in facilities where the product was installed, handled, maintained, or removed. Exposure occurred through several documented pathways that are characteristic of asbestos cement board products broadly.

Cutting and sawing represented one of the most significant sources of fiber release. When cement board panels were trimmed, shaped, or fitted to specific dimensions using hand saws, circular saws, or abrasive cutting tools, the mechanical action fractured the bonded matrix and released airborne chrysotile fibers into the immediate work environment. Without respiratory protection—which was rarely required or provided in the 1940s and early 1950s—workers in the immediate area and in adjacent zones inhaled these fibers during routine cutting operations.

Drilling and boring through installed panels created localized dust clouds containing asbestos fibers, particularly when workers were drilling in confined or poorly ventilated spaces such as mechanical rooms, utility corridors, or equipment housings.

Handling and transport of raw board stock also generated fiber release, particularly when panels were damaged, dropped, or abraded against other surfaces during loading, unloading, and staging on industrial worksites.

Maintenance and removal of previously installed cement board presented additional exposure risk. As the bonded material aged, weathered, or was damaged, the cement matrix could become friable, making the asbestos fibers more easily disturbed and released. Workers tasked with repairing or removing old installations during renovations or equipment overhauls were therefore exposed not only during original construction but potentially years or decades after initial installation.

Bystander and secondary exposure was also a documented concern in industrial settings where multiple trades worked simultaneously in shared spaces, as dust generated by one worker’s activities settled on surfaces, clothing, and tools used by others nearby.

OSHA’s permissible exposure limit (PEL) for asbestos, currently set at 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, did not exist during the period when Gold Bond Asbestos Cement Board was actively produced and installed. Workers of that era had no enforceable regulatory protection and often had no knowledge of the health risks associated with their work.

Gold Bond Asbestos Cement Board is a Tier 2 litigated product. There is no established asbestos bankruptcy trust fund associated with National Gypsum Company claims for this specific product that provides a direct administrative filing pathway for exposed workers.

Litigation records document claims brought against National Gypsum Company and related parties by individuals who alleged occupational exposure to asbestos-containing products manufactured under the Gold Bond brand. Plaintiffs alleged that National Gypsum Company knew or should have known of the hazards associated with asbestos-containing products and failed to adequately warn workers or the public of those risks.

Plaintiffs alleged that this failure to warn, combined with the continued manufacture and distribution of chrysotile-containing cement board products into the early 1950s, directly contributed to the development of asbestos-related diseases including mesothelioma, lung cancer, and asbestosis among workers who handled or worked near the product.

Individuals who believe they were exposed to Gold Bond Asbestos Cement Board and have subsequently been diagnosed with an asbestos-related disease should be aware of the following:

  • Civil litigation against responsible parties remains a potential avenue for compensation, subject to applicable state statutes of limitations. Many states apply a discovery rule that begins the limitations period at the time of diagnosis rather than the time of exposure.
  • Workers’ compensation claims may also be available depending on the jurisdiction and employment circumstances, though recoveries through this channel are often more limited than civil jury verdicts or settlements.
  • Multi-defendant asbestos cases frequently name numerous product manufacturers and premises owners, and exposure to Gold Bond Asbestos Cement Board may be one component of a broader occupational exposure history that is relevant to the overall claim.

Individuals with potential claims are strongly encouraged to consult with a qualified asbestos litigation attorney who can evaluate the full exposure history, applicable trust fund eligibility for other products encountered during the same work period, and litigation options specific to the jurisdiction where exposure or diagnosis occurred.